N-tert-butyl-2-[(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)amino]benzamide;2-[(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)amino]benzamide;N-[3-(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)oxyphenyl]acetamide;N-[4-(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)oxyphenyl]acetamide;tetrakis(2,2,2-trifluoroacetic acid)

C98H110F12N30O18 — CID 162133817

IUPACN-tert-butyl-2-[(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)amino]benzamide;2-[(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)amino]benzamide;N-[3-(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)oxyphenyl]acetamide;N-[4-(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)oxyphenyl]acetamide;tetrakis(2,2,2-trifluoroacetic acid)
SMILESCC#CCn1c(N2CCNCC2)nc2nc(Nc3ccccc3C(=O)NC(C)(C)C)n(C)c(=O)c21.CC#CCn1c(N2CCNCC2)nc2nc(Nc3ccccc3C(N)=O)n(C)c(=O)c21.CC#CCn1c(N2CCNCC2)nc2nc(Oc3ccc(NC(C)=O)cc3)n(C)c(=O)c21.CC#CCn1c(N2CCNCC2)nc2nc(Oc3cccc(NC(C)=O)c3)n(C)c(=O)c21.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
InChIInChI=1S/C25H32N8O2.2C22H25N7O3.C21H24N8O2.4C2HF3O2/c1-6-7-14-33-19-20(29-24(33)32-15-12-26-13-16-32)28-23(31(5)22(19)35)27-18-11-9-8-10-17(18)21(34)30-25(2,3)4;1-4-5-12-29-18-19(25-21(29)28-13-10-23-11-14-28)26-22(27(3)20(18)31)32-17-8-6-16(7-9-17)24-15(2)30;1-4-5-11-29-18-19(25-21(29)28-12-9-23-10-13-28)26-22(27(3)20(18)31)32-17-8-6-7-16(14-17)24-15(2)30;1-3-4-11-29-16-18(26-21(29)28-12-9-23-10-13-28)25-20(27(2)19(16)31)24-15-8-6-5-7-14(15)17(22)30;4*3-2(4,5)1(6)7/h8-11,26H,12-16H2,1-5H3,(H,27,28)(H,30,34);6-9,23H,10-14H2,1-3H3,(H,24,30);6-8,14,23H,9-13H2,1-3H3,(H,24,30);5-8,23H,9-13H2,1-2H3,(H2,22,30)(H,24,25);4*(H,6,7)
InChIKeyNKCNFZRSKAAFDF-UHFFFAOYSA-N
MW2224.13 g/mol
LogP7.40
Rot. Bonds20

About N-tert-butyl-2-[(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)amino]benzamide;2-[(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)amino]benzamide;N-[3-(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)oxyphenyl]acetamide;N-[4-(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)oxyphenyl]acetamide;tetrakis(2,2,2-trifluoroacetic acid)

N-tert-butyl-2-[(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)amino]benzamide;2-[(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)amino]benzamide;N-[3-(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)oxyphenyl]acetamide;N-[4-(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)oxyphenyl]acetamide;tetrakis(2,2,2-trifluoroacetic acid) (PubChem CID 162133817) has the molecular formula C98H110F12N30O18 and a molecular weight of 2224.13 g/mol. Its IUPAC name is N-tert-butyl-2-[(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)amino]benzamide;2-[(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)amino]benzamide;N-[3-(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)oxyphenyl]acetamide;N-[4-(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)oxyphenyl]acetamide;tetrakis(2,2,2-trifluoroacetic acid).

Molecular Properties

Compound NameN-tert-butyl-2-[(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)amino]benzamide;2-[(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)amino]benzamide;N-[3-(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)oxyphenyl]acetamide;N-[4-(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)oxyphenyl]acetamide;tetrakis(2,2,2-trifluoroacetic acid)
PubChem CID162133817
Molecular FormulaC98H110F12N30O18
Molecular Weight2224.13 g/mol
Exact Mass2222.84
IUPAC NameN-tert-butyl-2-[(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)amino]benzamide;2-[(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)amino]benzamide;N-[3-(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)oxyphenyl]acetamide;N-[4-(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)oxyphenyl]acetamide;tetrakis(2,2,2-trifluoroacetic acid)
SMILESCC#CCn1c(N2CCNCC2)nc2nc(Nc3ccccc3C(=O)NC(C)(C)C)n(C)c(=O)c21.CC#CCn1c(N2CCNCC2)nc2nc(Nc3ccccc3C(N)=O)n(C)c(=O)c21.CC#CCn1c(N2CCNCC2)nc2nc(Oc3ccc(NC(C)=O)cc3)n(C)c(=O)c21.CC#CCn1c(N2CCNCC2)nc2nc(Oc3cccc(NC(C)=O)c3)n(C)c(=O)c21.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
InChIInChI=1S/C25H32N8O2.2C22H25N7O3.C21H24N8O2.4C2HF3O2/c1-6-7-14-33-19-20(29-24(33)32-15-12-26-13-16-32)28-23(31(5)22(19)35)27-18-11-9-8-10-17(18)21(34)30-25(2,3)4;1-4-5-12-29-18-19(25-21(29)28-13-10-23-11-14-28)26-22(27(3)20(18)31)32-17-8-6-16(7-9-17)24-15(2)30;1-4-5-11-29-18-19(25-21(29)28-12-9-23-10-13-28)26-22(27(3)20(18)31)32-17-8-6-7-16(14-17)24-15(2)30;1-3-4-11-29-16-18(26-21(29)28-12-9-23-10-13-28)25-20(27(2)19(16)31)24-15-8-6-5-7-14(15)17(22)30;4*3-2(4,5)1(6)7/h8-11,26H,12-16H2,1-5H3,(H,27,28)(H,30,34);6-9,23H,10-14H2,1-3H3,(H,24,30);6-8,14,23H,9-13H2,1-3H3,(H,24,30);5-8,23H,9-13H2,1-2H3,(H2,22,30)(H,24,25);4*(H,6,7)
InChIKeyNKCNFZRSKAAFDF-UHFFFAOYSA-N
XLogP7.40
TPSA594.03 Ų
H-Bond Donors14
H-Bond Acceptors40
Rotatable Bonds20
Heavy Atoms158
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002224.13
LogP ≤ 57.40
H-Bond Donors ≤ 514
H-Bond Acceptors ≤ 1040

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze N-tert-butyl-2-[(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)amino]benzamide;2-[(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)amino]benzamide;N-[3-(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)oxyphenyl]acetamide;N-[4-(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)oxyphenyl]acetamide;tetrakis(2,2,2-trifluoroacetic acid) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-tert-butyl-2-[(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)amino]benzamide;2-[(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)amino]benzamide;N-[3-(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)oxyphenyl]acetamide;N-[4-(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)oxyphenyl]acetamide;tetrakis(2,2,2-trifluoroacetic acid)?
The IUPAC name of N-tert-butyl-2-[(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)amino]benzamide;2-[(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)amino]benzamide;N-[3-(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)oxyphenyl]acetamide;N-[4-(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)oxyphenyl]acetamide;tetrakis(2,2,2-trifluoroacetic acid) (CID 162133817) is N-tert-butyl-2-[(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)amino]benzamide;2-[(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)amino]benzamide;N-[3-(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)oxyphenyl]acetamide;N-[4-(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)oxyphenyl]acetamide;tetrakis(2,2,2-trifluoroacetic acid).
What is the SMILES notation for N-tert-butyl-2-[(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)amino]benzamide;2-[(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)amino]benzamide;N-[3-(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)oxyphenyl]acetamide;N-[4-(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)oxyphenyl]acetamide;tetrakis(2,2,2-trifluoroacetic acid)?
The canonical SMILES for N-tert-butyl-2-[(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)amino]benzamide;2-[(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)amino]benzamide;N-[3-(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)oxyphenyl]acetamide;N-[4-(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)oxyphenyl]acetamide;tetrakis(2,2,2-trifluoroacetic acid) is CC#CCn1c(N2CCNCC2)nc2nc(Nc3ccccc3C(=O)NC(C)(C)C)n(C)c(=O)c21.CC#CCn1c(N2CCNCC2)nc2nc(Nc3ccccc3C(N)=O)n(C)c(=O)c21.CC#CCn1c(N2CCNCC2)nc2nc(Oc3ccc(NC(C)=O)cc3)n(C)c(=O)c21.CC#CCn1c(N2CCNCC2)nc2nc(Oc3cccc(NC(C)=O)c3)n(C)c(=O)c21.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.
What is the InChIKey of N-tert-butyl-2-[(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)amino]benzamide;2-[(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)amino]benzamide;N-[3-(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)oxyphenyl]acetamide;N-[4-(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)oxyphenyl]acetamide;tetrakis(2,2,2-trifluoroacetic acid)?
The InChIKey is NKCNFZRSKAAFDF-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H32N8O2.2C22H25N7O3.C21H24N8O2.4C2HF3O2/c1-6-7-14-33-19-20(29-24(33)32-15-12-26-13-16-32)28-23(31(5)22(19)35)27-18-11-9-8-10-17(18)21(34)30-25(2,3)4;1-4-5-12-29-18-19(25-21(29)28-13-10-23-11-14-28)26-22(27(3)20(18)31)32-17-8-6-16(7-9-17)24-15(2)30;1-4-5-11-29-18-19(25-21(29)28-12-9-23-10-13-28)26-22(27(3)20(18)31)32-17-8-6-7-16(14-17)24-15(2)30;1-3-4-11-29-16-18(26-21(29)28-12-9-23-10-13-28)25-20(27(2)19(16)31)24-15-8-6-5-7-14(15)17(22)30;4*3-2(4,5)1(6)7/h8-11,26H,12-16H2,1-5H3,(H,27,28)(H,30,34);6-9,23H,10-14H2,1-3H3,(H,24,30);6-8,14,23H,9-13H2,1-3H3,(H,24,30);5-8,23H,9-13H2,1-2H3,(H2,22,30)(H,24,25);4*(H,6,7).
What are the key properties of N-tert-butyl-2-[(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)amino]benzamide;2-[(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)amino]benzamide;N-[3-(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)oxyphenyl]acetamide;N-[4-(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)oxyphenyl]acetamide;tetrakis(2,2,2-trifluoroacetic acid)?
N-tert-butyl-2-[(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)amino]benzamide;2-[(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)amino]benzamide;N-[3-(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)oxyphenyl]acetamide;N-[4-(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)oxyphenyl]acetamide;tetrakis(2,2,2-trifluoroacetic acid) has a molecular weight of 2224.13 g/mol, XLogP of 7.40, 20 rotatable bonds, 14 hydrogen bond donors, and 40 hydrogen bond acceptors.
Where does this data come from?
All data for N-tert-butyl-2-[(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)amino]benzamide;2-[(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)amino]benzamide;N-[3-(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)oxyphenyl]acetamide;N-[4-(7-but-2-ynyl-1-methyl-6-oxo-8-piperazin-1-ylpurin-2-yl)oxyphenyl]acetamide;tetrakis(2,2,2-trifluoroacetic acid) is sourced from PubChem (CID 162133817), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).